BioAge Labs, Inc. financial data

Symbol
BIOA on Nasdaq
Location
Emeryville, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1289% %
Debt-to-equity 10% %
Return On Equity -25% % -121%
Return On Assets -23% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35,855,037 shares 0.02%
Common Stock, Shares, Outstanding 35,850,037 shares 4.8%
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 35,850,037 shares 926%
Weighted Average Number of Shares Outstanding, Diluted 35,850,037 shares 926%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $2,054,000 USD
Research and Development Expense $68,691,000 USD -7.5%
General and Administrative Expense $26,945,000 USD 41%
Operating Income (Loss) $89,719,000 USD 6.5%
Nonoperating Income (Expense) $13,928,000 USD 121%
Net Income (Loss) Attributable to Parent $75,791,000 USD -6.8%
Earnings Per Share, Basic 14 USD/shares 92%
Earnings Per Share, Diluted 14 USD/shares 92%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $215,573,000 USD -36%
Marketable Securities, Current $70,205,000 USD
Accounts Receivable, after Allowance for Credit Loss, Current $515,000 USD
Assets, Current $290,828,000 USD -14%
Property, Plant and Equipment, Net $973,000 USD 79%
Operating Lease, Right-of-Use Asset $2,884,000 USD 964%
Other Assets, Noncurrent $227,000 USD
Assets $305,090,000 USD -9.6%
Accounts Payable, Current $5,018,000 USD 139%
Employee-related Liabilities, Current $3,160,000 USD 6.5%
Contract with Customer, Liability, Current $7,506,000 USD
Liabilities, Current $24,493,000 USD 28%
Contract with Customer, Liability, Noncurrent $556,000 USD
Operating Lease, Liability, Noncurrent $2,427,000 USD
Liabilities $27,626,000 USD 17%
Accumulated Other Comprehensive Income (Loss), Net of Tax $275,000 USD 152%
Retained Earnings (Accumulated Deficit) $307,473,000 USD -33%
Stockholders' Equity Attributable to Parent $277,464,000 USD -12%
Liabilities and Equity $305,090,000 USD -9.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 35,850,037 shares 4.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Operating Lease, Liability $3,007,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $75,741,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid $4,131,000 USD
Property, Plant and Equipment, Gross $1,386,000 USD 28%
Operating Lease, Liability, Current $580,000 USD 112%
Lessee, Operating Lease, Liability, to be Paid, Year Two $763,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $617,000 USD 208%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,124,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $786,000 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $810,000 USD
Additional Paid in Capital $584,662,000 USD 7.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $11,690,000 USD 51%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%